Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Ensysce Biosciences Inc
(NQ:
ENSC
)
0.4156
+0.0056 (+1.37%)
Streaming Delayed Price
Updated: 11:23 AM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Ensysce Biosciences Inc
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
May 10, 2023
Via
Benzinga
Ensysce Biosciences, Inc. Announces Pricing of $7 Million Public Offering
May 10, 2023
Via
ACCESSWIRE
Why Is Ensysce Biosciences (ENSC) Stock Up 50% Today?
May 09, 2023
With Ensysce Biosciences achieving testing success regarding its overdose protection drug, ENSC stock soared on the implications.
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's Intraday Session
May 09, 2023
Via
Benzinga
Ensysce Biosciences Announces Successful Completion of Ground-Breaking Study on Overdose Protection
May 09, 2023
Via
ACCESSWIRE
Ensysce CEO Dr. Lynn Kirkpatrick To Present Featured Case Study of MPAR Overdose Protection Platform Accelerated Development
April 19, 2023
Via
ACCESSWIRE
Ensysce Biosciences Announces Updated Investor Presentation Available Via Investor Relations Website
April 11, 2023
Via
ACCESSWIRE
Ensysce Biosciences's Return On Capital Employed Overview
April 03, 2023
Via
Benzinga
Why PRA Group Shares Are Trading Lower By 44%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
May 09, 2023
Gainers TScan Therapeutics, Inc. (NASDAQ: TCRX) shares gained 118% to $4.68 after the company and Amgen announced collaboration to identify novel targets in Crohn's disease.
Via
Benzinga
Ensysce Biosciences (NASDAQ: ENSC) Successfully Completes Overdose-Protection Study
May 09, 2023
Ensysce Biosciences, Inc. (NASDAQ: ENSC) operates as a clinical-stage biotechnology company, which is focused on leveraging its proprietary technology to
Via
Spotlight Growth
Exposures
Product Safety
Ensysce Biosciences Announces Positive Results from Oral Human Abuse Potential Trial for PF614
April 03, 2023
Via
ACCESSWIRE
Ensysce Biosciences Reports Fourth Quarter and Full Year 2022 Financial Results
March 30, 2023
Via
ACCESSWIRE
Ensysce Biosciences Announces Completion of Enrollment for Groundbreaking Opioid Overdose Protection Study
March 22, 2023
Via
ACCESSWIRE
Why Are Ensysce Biosciences Shares Are Trading Higher Today
May 09, 2023
Ensysce Biosciences Inc (NASDAQ: ENSC) completed PF614-MPAR-101, a clinical study examining the company's first pain medication with overdose protection,
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
May 09, 2023
Via
Benzinga
Why Travelers Companies Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
April 19, 2023
Gainers China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) gained 85.2% to $1.25 after the company announced the termination of its previously proposed registered direct offering.
Via
Benzinga
Dr. Lynn Kirkpatrick, Featured Speaker to Discuss Ensysce Overdose Protection Platform at DCAT Seminar
March 06, 2023
Via
ACCESSWIRE
Ensysce Biosciences Announces Critical Step in Human Abuse Potential Study of PF614 With Database Lock
February 28, 2023
Via
ACCESSWIRE
Ensysce Biosciences Provides Corporate Update
February 23, 2023
Via
ACCESSWIRE
Stocks That Hit 52-Week Lows On Monday
April 03, 2023
On Monday, 76 companies set new 52-week lows.
Via
Benzinga
Ensysce Biosciences, AST SpaceMobile, IGM Biosciences And Other Big Stocks Moving Lower On Friday
March 31, 2023
U.S. stocks traded higher, with the Dow Jones gaining more than 200 points on Friday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
Why Y-mAbs Therapeutics Shares Are Trading Higher By 50%? Here Are Other Stocks Moving In Friday's Mid-Day Session
March 31, 2023
Gainers Y-mAbs Therapeutics, Inc (NASDAQ: YMAB) climbed 49.9% to $4.93 after the company posted a profit for the fourth quarter.
Via
Benzinga
Ensysce Biosciences And 2 Other Stocks Under $2 Insiders Are Aggressively Buying
March 07, 2023
The Dow Jones rose around 40 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny...
Via
Benzinga
ObsEva, Ensysce Biosciences And 2 Other Stocks Under $1 Insiders Are Aggressively Buying
March 03, 2023
The Dow Jones jumped by more than 300 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
February 28, 2023
During Tuesday, 79 stocks hit new 52-week lows.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
February 15, 2023
Via
Benzinga
Ensysce Biosciences Receives Positive Nasdaq Listing Determination
February 15, 2023
Via
ACCESSWIRE
Ensysce Biosciences to Present its Overdose Protection Program at the 4th Annual NIH 'HELPING END ADDICTION LONG-TERM' (HEAL) Meeting
February 14, 2023
Via
ACCESSWIRE
Ensysce Biosciences, Inc. Announces Closing of $3.0 Million Registered Direct Offering Priced at-the-Market Under NASDAQ Rules
February 07, 2023
Via
ACCESSWIRE
Ensysce Biosciences, Inc. Announces $3 Million Registered Direct Offering
February 03, 2023
Via
ACCESSWIRE
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.